TY - JOUR
T1 - Is the new euroscore II a better predictor for transapical aortic valve implantation?
AU - Haensig, Martin
AU - Holzhey, David Michael
AU - Borger, Michael Andrew
AU - Schuler, Gerhard
AU - Shi, William
AU - Subramanian, Sreekumar
AU - Rastan, Ardawan Julian
AU - Mohr, Friedrich Wilhelm
PY - 2013/7
Y1 - 2013/7
N2 - Objectives: Conventional surgical risk scores are used to identify suitable candidates for transapical aortic valve implantation (TA-AVI) at present. However, these scores do not consider multiple high-risk conditions, including porcelain aorta, mediastinal irradiation or frailty. The aim of this study was to compare the predictive ability of the new EuroSCORE II with the surgical risk scores currently in use. Methods: From February 2006 to May 2011, 360 consecutive high-risk patients, age 81.6 μ 6.4 years, 64.4% female, were included using the Edwards SAPIEN™ prosthesis. The prognostic value of the EuroSCORE II was evaluated and compared with the logistic EuroSCORE and STS mortality score by receiver operating characteristics (ROC) curve analysis. In addition, a Spearman correlation analysis was performed, and a stepwise multivariate Cox regression used to identify the independent risk factors of mortality. Results: The STS score and EuroSCORE II (r = 0.504, P < 0.001) showed a good correlation, while a strong correlation was found between the logistic EuroSCORE and EuroSCORE II (r = 0.717, P < 0.001). Thirty-day and in-hospital mortality rates were 10.6% (38 of 360) and 11.4% (41 of 360), respectively. In-hospital mortality rate was estimated by the logistic EuroSCORE: 30.0 μ 15.7%, the STS score: 11.7 μ 7.8% and the EuroSCORE II: 6.7 μ 5.1%. The prognostic values of the STS score, logistic EuroSCORE and the recent EuroSCORE II systems were analysed by ROC curve analysis for the prediction of 30-day (area under the curve, AUC: 0.64 vs 0.55 vs 0.50) and in-hospital mortality (AUC: 0.65 vs 0.54 vs 0.49). Multivariate regression analysis revealed length of preoperative hospital stay >5 days, body weight <65 kg, preoperative aortic annular diameter =20 mm, vital capacity <70% and concomitant mitral regurgitation >1+ as independent risk factors. Conclusion: In patients undergoing TA-AVI, the new EuroSCORE II correlates strongly with the logistic EuroSCORE, but is a poorer predictor of 30-day and in-hospital mortality than the STS score. A true transcatheter aortic valve implantation risk score would be desirable beyond the established scores.
AB - Objectives: Conventional surgical risk scores are used to identify suitable candidates for transapical aortic valve implantation (TA-AVI) at present. However, these scores do not consider multiple high-risk conditions, including porcelain aorta, mediastinal irradiation or frailty. The aim of this study was to compare the predictive ability of the new EuroSCORE II with the surgical risk scores currently in use. Methods: From February 2006 to May 2011, 360 consecutive high-risk patients, age 81.6 μ 6.4 years, 64.4% female, were included using the Edwards SAPIEN™ prosthesis. The prognostic value of the EuroSCORE II was evaluated and compared with the logistic EuroSCORE and STS mortality score by receiver operating characteristics (ROC) curve analysis. In addition, a Spearman correlation analysis was performed, and a stepwise multivariate Cox regression used to identify the independent risk factors of mortality. Results: The STS score and EuroSCORE II (r = 0.504, P < 0.001) showed a good correlation, while a strong correlation was found between the logistic EuroSCORE and EuroSCORE II (r = 0.717, P < 0.001). Thirty-day and in-hospital mortality rates were 10.6% (38 of 360) and 11.4% (41 of 360), respectively. In-hospital mortality rate was estimated by the logistic EuroSCORE: 30.0 μ 15.7%, the STS score: 11.7 μ 7.8% and the EuroSCORE II: 6.7 μ 5.1%. The prognostic values of the STS score, logistic EuroSCORE and the recent EuroSCORE II systems were analysed by ROC curve analysis for the prediction of 30-day (area under the curve, AUC: 0.64 vs 0.55 vs 0.50) and in-hospital mortality (AUC: 0.65 vs 0.54 vs 0.49). Multivariate regression analysis revealed length of preoperative hospital stay >5 days, body weight <65 kg, preoperative aortic annular diameter =20 mm, vital capacity <70% and concomitant mitral regurgitation >1+ as independent risk factors. Conclusion: In patients undergoing TA-AVI, the new EuroSCORE II correlates strongly with the logistic EuroSCORE, but is a poorer predictor of 30-day and in-hospital mortality than the STS score. A true transcatheter aortic valve implantation risk score would be desirable beyond the established scores.
KW - Aortic valve implantation
KW - Euroscore
KW - Minimally invasive
KW - Transapical
UR - http://www.scopus.com/inward/record.url?scp=84880658313&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880658313&partnerID=8YFLogxK
U2 - 10.1093/ejcts/ezt038
DO - 10.1093/ejcts/ezt038
M3 - Article
C2 - 23423917
AN - SCOPUS:84880658313
SN - 1010-7940
VL - 44
SP - 302
EP - 308
JO - European Journal of Cardio-thoracic Surgery
JF - European Journal of Cardio-thoracic Surgery
IS - 2
ER -